Variants in GLP1R , the direct biological target, and MC4R , central to satiety and energy balance, describe part of the terrain the compound acts on
NAD and NMN : biologically interesting, clinically unproven
They are only licensed for type 2 diabetes and obesity management
It also generates foam that makes it impossible to verify whether the powder has fully dissolved
Peptide describes what the molecule is: a chain of amino acids
Last reviewed: June 29, 2026 Last updated: June 29, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations